Insider Transactions in Q1 2023 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,233
-0.39%
|
$332,718
$46.54 P/Share
|
|
Feb 18
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,307
+0.87%
|
-
|
|
Feb 18
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,002
-1.07%
|
$46,092
$46.54 P/Share
|
|
Feb 18
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,817
+2.92%
|
-
|
|
Feb 17
2023
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
685
-1.81%
|
$31,510
$46.54 P/Share
|
|
Feb 17
2023
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+3.81%
|
-
|
|
Feb 17
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
421
-1.22%
|
$19,366
$46.54 P/Share
|
|
Feb 17
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+2.81%
|
-
|
|
Feb 17
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,448
-2.23%
|
$66,608
$46.54 P/Share
|
|
Feb 17
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+3.71%
|
-
|
|
Feb 17
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
294
-0.72%
|
$13,524
$46.54 P/Share
|
|
Feb 17
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+2.39%
|
-
|
|
Feb 17
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,033
-0.72%
|
$93,518
$46.54 P/Share
|
|
Feb 17
2023
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,583
+1.59%
|
-
|
|
Feb 17
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
998
-1.07%
|
$45,908
$46.54 P/Share
|
|
Feb 17
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+2.36%
|
-
|
|
Feb 17
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,257
-4.38%
|
$57,822
$46.54 P/Share
|
|
Feb 17
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,833
+8.99%
|
-
|
|
Feb 17
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
2,056
-0.94%
|
$94,576
$46.54 P/Share
|
|
Feb 17
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+1.87%
|
-
|
|
Feb 17
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,131
-0.44%
|
$374,026
$46.54 P/Share
|
|
Feb 17
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,333
+0.99%
|
-
|
|
Feb 17
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
2,061
-2.22%
|
$94,806
$46.35 P/Share
|
|
Feb 17
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,020
-1.09%
|
$46,920
$46.54 P/Share
|
|
Feb 17
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+3.43%
|
-
|
|
Feb 16
2023
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
581
-1.57%
|
$26,726
$46.48 P/Share
|
|
Feb 16
2023
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,272
+3.33%
|
-
|
|
Feb 16
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
456
-1.34%
|
$20,976
$46.48 P/Share
|
|
Feb 16
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
990
+2.83%
|
-
|
|
Feb 16
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,310
-2.06%
|
$60,260
$46.48 P/Share
|
|
Feb 16
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,262
+3.43%
|
-
|
|
Feb 16
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
568
-1.4%
|
$26,128
$46.48 P/Share
|
|
Feb 16
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,838
+4.35%
|
-
|
|
Feb 16
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,250
-0.45%
|
$57,500
$46.48 P/Share
|
|
Feb 16
2023
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,243
+1.49%
|
-
|
|
Feb 16
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
910
-0.99%
|
$41,860
$46.48 P/Share
|
|
Feb 16
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,050
+2.19%
|
-
|
|
Feb 16
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,129
-4.19%
|
$51,934
$46.48 P/Share
|
|
Feb 16
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,545
+8.62%
|
-
|
|
Feb 16
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,806
-0.84%
|
$83,076
$46.48 P/Share
|
|
Feb 16
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,960
+1.8%
|
-
|
|
Feb 16
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,214
-0.39%
|
$331,844
$46.48 P/Share
|
|
Feb 16
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,264
+0.88%
|
-
|
|
Feb 16
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
1,409
-1.53%
|
$64,814
$46.79 P/Share
|
|
Feb 16
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
909
-0.98%
|
$41,814
$46.48 P/Share
|
|
Feb 16
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,970
+3.1%
|
-
|
|
Feb 15
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
7,572
-2.67%
|
$355,884
$47.14 P/Share
|
|
Feb 15
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,219
-0.43%
|
$57,293
$47.29 P/Share
|
|
Feb 15
2023
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,725
+2.03%
|
$35,175
$3.7 P/Share
|
|
Feb 15
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
323
-0.83%
|
$15,181
$47.29 P/Share
|